Introduction
patients with ESRD [2] [3] [4] [5] . Although the reported incidence of depression in patients maintained on The impact of psychosocial factors on the outcome of dialysis varies widely, these differences have been patients with end-stage renal disease ( ESRD) has been attributed to the differing criteria and methodology receiving more attention recently [1] [2] [3] [4] . The progress-used to diagnose depression [2, 5] . It is important to ive increase in both the incidence and prevalence of be clear what exactly is meant by depression. Although patients with ESRD throughout the world, the high depressive symptomatology is commonly encountered mortality rate and rising costs of providing care for in dialysis patients, the syndrome of clinical depression patients with ESRD [1] have focused research interest consists of the presence of a constellation of symptoms on those aspects of ESRD care which affect patient including anhedonia and feelings of sadness, helpoutcomes and are potentially amenable to modification lessness, guilt, hopelessness, etc. and is accompanied to improve these outcomes.
by changes in sleep, appetite, and libido. Recent studies that have employed the Beck's Depression Inventory (BDI )-a standard self-administered questionnaire
Psychological factors-important predictions of
commonly used in psychiatric practice to screen patient outcome patients for depression-have reported remarkably similar findings [4, 5, 7] . These studies note that between Although the psychological and social difficulties one-third and one-half of dialysis patients have scores experienced by patients maintained on dialysis have suggesting the presence of at least a moderate degree been noted and commented on for some time, it has of depression (BDI scores of 11 or greater). been only recently that researchers have begun to Furthermore, Wuerth et al. observed that when these demonstrate that psychosocial factors are important patients were then evaluated by a trained psychiatric predictors of patient outcome [2] [3] [4] [5] . For example, as interviewer for the presence of clinical depression, 85% the SF-36 Quality of Life and the Kidney Disease of dialysis patients with BDI scores of 11 or greater Quality of Life ( KdQofL) questionnaires have become met the DSM IV criteria for the diagnosis of major widely used, it is apparent that dialysis patients have depression and had scores of 17 or more on the 21-item higher scores on the emotional components of these Hamilton Depression Scale (unpublished observation). assessments than controls, indicating, perhaps not sur-These patients were, therefore, candidates for antiprisingly, that emotional difficulties are present in depressant medication by standard psychiatric practice dialysis patients. However, what is particularly note-guidelines. worthy is that scores on the emotional components of these questionnaires are in fact strong predictors of Depression scores (BDI ) predict survival in patient outcome [6 ] . Thus, in the data base of Fresenius
dialysed patients
Medical Care in the United States, Lowrie et al. have demonstrated that dialysis patients with scores lower than 51 on the Mental Component Scale of the SF-36 Does depression in fact impact on long term patient have progressively increasing risks of death. In fact, morbidity and/or mortality in patients maintained on the patients with scores of 0-37 have twice the relative dialysis? Depression has clearly been demonstrated to risk of death than those patients with scores of 51 or predict mortality in a variety of medical conditions higher [6 ] . [8, 9] . However, demonstrating the impact of depression on morbidity and mortality in patients with ESRD has proved to be more difficult [10] . Of particular note, however, are three recent studies [4, 7, 11, 12] . analysis in a large cohort of hemodialysis patients in depressant medication with a 50% reduction in their scores on the BDI from a mean±SD score of 17.1±6.9 whom BDI questionnaires were administered every 6 months [4] . Since the BDI scores change over time, to 8.6±3.2 (P=0.003). Thus, although 50% of the patients had BDI scores suggesting at least a moderate these authors used a time-varying covariate analysis and were able to clearly demonstrate a significant degree of depressive symptomatology, only 11 of these 60 patients (18%) completed a 12 week course correlation between depression scores and mortality with both a single variable and multivariable analysis of therapy. Many patients refused either further psychological evaluation or were unwilling to take [4] . BDI scores predicted mortality with a relative risk of 1.24 [95% CI: 1.05-1.46, P=0.01]. Juergensen et al. anti-depressant drugs in addition to their standard medications. The anti-depressants used in this study examined a large cohort of patients maintained on chronic peritoneal dialysis (CPD) and demonstrated a [sertraline, nefazodone, and bupropion] were well tolerated with few side effects, although the doses used relationship between a variety of psychosocial parameters and the incidence of peritonitis [11, 12] . In these were relatively low. In this study, the investigators did not comment on the correlation between the treatment studies, patients who had more than one episode of peritonitis had higher levels of anxiety and depression of depression and patient outcomes. It must be kept in mind that careful follow-up and outcome studies of and a poorer overall quality of life assessment than patients with lower rates of peritonitis [11] . patients with ESRD treated for depression are essential, particularly in view of the recent reports describing Furthermore, patients who had scores on the BDI of 11 or greater had peritonitis rates that were twice the an association between the use of antidepressant medication and various adverse medical outcomes. For rate of patients with low BDI scores [12] . Since peritonitis is the major reason for technique failure and example, Cohen et al and Roose et al. observed an increased risk of myocardial infarction or adverse hospitalization for patients maintained on CPD [13] , these data may well suggest an association between cardiac events in patients receiving tricyclic antidepressants, but not selective serotonin reuptake inhibthese psychosocial factors and hospitalization and technique failure rates in patients maintained on CPD. itors (SSRI ) [15, 16 ] . Thapa et al. noted an increased risk of falls in nursing home residents receiving both Finally, Steele et al. examined the relationships between patient assessed quality of life and a variety of medical tricyclic and SSRI anti-depressants compared to residents not receiving anti-depressant medication [17] . and psychological variables and observed that depressive symptoms (as assessed by the BDI ) proved to be a much stronger correlate of overall quality of life than Conclusions dialysis adequacy [7] .
In summary, the available information would suggest
Treatment of depression
that: i ] clinical depression is commonly encountered in patients with ESRD, ii] the BDI is an easily administered questionnaire that is a useful screen for potenBut is the clinical depression of the patient maintained on dialysis amenable to therapy or does it just represent tially treatable clinical depression in this patient population, iii ] it is challenging to organize an effective an untreatable manifestation of the patient's chronic illness? Does the higher mortality and morbidity in medication treatment program of depression for patients with ESRD, iv] anti-depressant medication ESRD patients with depression simply reflect a psychological response to a poorer overall medical condition? can result in a significant improvement in depressive symptomatology, v] anti-depressant medication is The treatment of depression in patients with ESRD with anti-depressant medication presents challenging often well tolerated by patients with ESRD, vi ] whether this improvement in depressive symptomatology evenproblems and has been addressed in few studies systematically. Kennedy et al. described the successful treat-tually results in improved patient outcomes requires further investigation. ment of major clinical depression in a small group of dialysis patients using desipramine in five patients and Based on these observations, we have instituted a program in our dialysis units of screening patients maprotiline in one patient, with a significant reduction in BDI scores observed after seven weeks of therapy every 6 months with the BDI. Patients with scores of 11 or greater are referred to a trained psychiatric [14] . The more recent study by Wuerth et al. describes the successful treatment of depression in a cohort of interviewer. If the patient has a score on the 21-item Hamilton Depression Scale of 17 or greater and meets patients maintained on CPD while underscoring the difficulty in successfully using antidepressant medica-the DSM-IV criteria for depression, anti-depressant medication is prescribed and the patient is carefully tion in dialysis patients (unpublished observations). In this study, about 130 patients completed BDI question-monitored.
It is hoped that if the personnel (nurses, physicians, naires and about half had scores of 11 or greater, suggesting at least a moderate degree of depression. social workers, nephrology trainees) caring for patients with ESRD in the dialysis centers are made increasingly Of those patients who were felt to be candidates for further investigation, only half agreed to further evalu-aware of the possible treatment options available for patients with clinical depression, effective treatment ation by a trained psychiatric team. Of those patients, half successfully completed a 12 week course of anti-strategies can be devised and at least some of the Psychosocial influences on mortality after myocardial infarction.
suffering, morbidity and mortality of the patients 
